TipRanks
Go Ultimate55% OFF

CPH Group AG Class A (CPHN) AI Stock Analysis

Top Page

CH:CPHN

CPH Group AG Class A

(Six Swiss:CPHN)

Select Model
Rating:55Neutral
Price Target:CHF 59.00â–²(2.79% Upside)
Action:reiterated
Date:08/05/26

CPH Group earns a score of 55, reflecting a company in transition that has stabilized after a severe revenue contraction. The most significant factor is the mixed financial performance: while margins and profitability have recovered meaningfully (gross margin at 47.7%, ROE at 11.5%), the business is operating at roughly half its 2022 revenue scale with a diminished equity base. Valuation is fair with a supportive 3.45% dividend yield and a reasonable P/E of 16.9x, providing some downside cushion. Technical indicators are neutral, with the stock trading below its 200-DMA, suggesting the longer-term trend remains cautious. The low beta (0.33) offers defensive qualities but also limits upside participation in broader market rallies. Key risks include the cyclical nature of the industry, uncertain revenue growth prospects, and declining cash flow generation capacity.

Positive Factors
Profitability reboundThe 2025 margin recovery (roughly 48% gross and 7% net) suggests improved pricing, mix or cost control in specialty chemicals and/or tighter portfolio management. Sustained margins bolster internal cash available for reinvestment, dividends and buffer against cyclical downturns over the medium term.
Negative Factors
Revenue cyclicalityHistoric cyclicality and a prior major loss year underline that end-market exposure (petrochemical, gas drying, life-science purification) drives uneven revenue and profit. Such volatility weakens predictability of earnings, complicates capital allocation and increases the need for conservative balance-sheet management.

CPH Group AG Class A (CPHN) vs. iShares MSCI Switzerland ETF (EWL)

-20%-10%0%10%20%CH:CPHN-13.64%EWL+18.85%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
CHF 344.12M
Dividend Yield
3.48%
Average Volume (3M)
2,361
Price to Earnings (P/E)
16.7
Beta (1Y)
0.32
Revenue Growth
3.69%
EPS Growth
-32.66%
Country
Switzerland
Employees
1,249
Sector
General
Sector Strength
55
Industry
Paper, Lumber & Forest Products

CPH Group AG Class A Business Overview & Revenue Model

Company Description

CPH Chemie + Papier Holding AG, along with its various group entities, focuses on the innovation, manufacture, and commercialization of chemicals, paper for printing, and specialized packaging films for the pharmaceutical sector. The Chemistry segmen...

How the Company Makes Money

CPH Group AG generates revenue primarily through two pillars: (1) its specialty chemicals business and (2) its real estate business. In specialty chemicals, the Zeochem segment sells molecular sieves, chromatography gels, and related adsorbent/proces...

CPH Group AG Class A Financial Statement Overview

Summary

CPH Group shows stabilization after a dramatic revenue contraction (~54% from 2022 peak). Positives include gross margin recovery to 47.7%, net profit margin rebound to 7.0%, improving ROE at 11.5%, and positive free cash flow growth of 60% YoY. However, the massive revenue decline, reduced equity base (CHF 204M vs CHF 436M in 2023), rising debt-to-equity (0.26), and weakening operating cash flow coverage (0.30) temper the outlook. The income statement score of 52, balance sheet score of 58, and cash flow score of 55 collectively reflect a company that is leaner and more profitable but significantly smaller and still navigating cyclical headwinds.

Income Statement

52Neutral

Balance Sheet

58Neutral

Cash Flow

55Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue334.23M334.06M447.86M623.98M725.35M496.69M
Gross Profit116.05M159.50M162.31M224.67M125.21M-2.92M
EBITDA47.16M49.06M30.90M113.06M131.09M-117.87M
Net Income20.49M23.36M4.65M78.89M100.95M-151.56M
Balance Sheet
Total Assets392.86M368.86M332.61M598.19M666.19M560.40M
Cash, Cash Equivalents and Short-Term Investments32.96M27.04M31.60M107.64M143.61M95.12M
Total Debt58.40M53.23M18.94M723.00K98.85M109.82M
Total Liabilities182.58M164.99M123.16M161.92M266.62M249.90M
Stockholders Equity210.27M203.50M209.45M436.27M398.21M309.13M
Cash Flow
Free Cash Flow30.18M12.82M22.69M75.22M63.72M-8.76M
Operating Cash Flow50.50M34.07M45.68M109.86M97.63M15.83M
Investing Cash Flow-33.45M-50.89M-46.74M-18.00M-29.62M-19.22M
Financing Cash Flow-10.60M13.52M-75.52M-125.66M-18.99M-17.98M

CPH Group AG Class A Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

CH:CPHN against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
CH:MIKNCH:MIKN76OutperformCHF 247.26M8.9911.74%3.97%-1.24%-11.13%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
CH:CPHNCH:CPHN55NeutralCHF 344.38M16.73―3.48%3.69%-32.66%
CH:BYSCH:BYS55NeutralCHF 318.90M-7.71-7.19%2.59%-1.69%30.59%
CH:MEDXCH:MEDX53NeutralCHF 434.08M4208.00―0.95%-6.64%―
CH:VETNCH:VETN53NeutralCHF 363.97M-102.00―2.72%-4.83%-139.13%
CH:KOMNCH:KOMN44NeutralCHF 371.22M-39.56――-2.66%9.28%

* General Sector Average

Performance Comparison

-40%-20%0%20%CH:CPHNCH:KOMNCH:BYSCH:MIKNCH:VETNCH:MEDXDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
CH:CPHN and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
CH:CPHNCPH Group AG Class A57.40-10.23-15.13%
CH:KOMNKomax Holding72.407.0010.70%
CH:BYSBystronic AG154.20-134.19-46.53%
CH:MIKNMikron Holding AG15.10-5.28-25.92%
CH:VETNVetropack Holding AG Class A18.36-2.44-11.72%
CH:MEDXmedmix AG10.521.6218.19%

CPH Group AG Class A Corporate Events

CPH Group Lifts Payout Ratio as Packaging Strength Offsets Zeochem Slowdown

Jul 21, 2026

CPH Group reported stable first-half 2026 sales of CHF 176 million and EBITDA of CHF 28.3 million, with an improved EBITDA margin of 16.1% back in its target range, supported by cost reductions and a richer product mix at Perlen Packaging. Net profit...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 04, 2026